Possible autocrine loop of the epidermal growth factor system in patients with benign prostatic hyperplasia treated with finasteride: a placebo-controlled randomized study

Niels Tørring; Klaus Møller-Ernst Jensen; L Lund; J E Nielsen; Jens Christian Djurhuus; S S Poulsen; Ebba Nexø; Steen Seier Poulsen

Possible autocrine loop of the epidermal growth factor system in patients with benign prostatic hyperplasia treated with finasteride: a placebo-controlled randomized study

Niels Tørring, Klaus Møller-Ernst Jensen, L Lund, J E Nielsen, Jens Christian Djurhuus, S S Poulsen, Ebba Nexø, Steen Seier Poulsen

9 Citations (Scopus)

Abstract

To analyse the expression of the epidermal growth factor (EGF) system in prostate tissue and secretions obtained from patients with benign prostatic hyperplasia (BPH) treated with or without finasteride (which primarily targets the androgen-sensitive secretory epithelial cells in the prostate, with little effect on basal epithelial and stromal cells).

Original language	English
Journal	B J U International (Print)
Volume	89
Issue number	6
Pages (from-to)	583-90
Number of pages	8
ISSN	1464-4096
Publication status	Published - 1 Apr 2002

Keywords

Epidermal Growth Factor
Finasteride
Glycoproteins
Growth Substances
Humans
Immunohistochemistry
Intercellular Signaling Peptides and Proteins
Male
Prospective Studies
Prostatic Hyperplasia
Receptor, Epidermal Growth Factor
Receptor, erbB-2
Transforming Growth Factor alpha

Cite this

Possible autocrine loop of the epidermal growth factor system in patients with benign prostatic hyperplasia treated with finasteride: a placebo-controlled randomized study. / Tørring, Niels; Jensen, Klaus Møller-Ernst; Lund, L et al.

In: B J U International (Print), Vol. 89, No. 6, 01.04.2002, p. 583-90.

Research output: Contribution to journal › Journal article › Research › peer-review

@article{742d08e39a6c4d9aba2a14bcda5df425,

title = "Possible autocrine loop of the epidermal growth factor system in patients with benign prostatic hyperplasia treated with finasteride: a placebo-controlled randomized study",

abstract = "To analyse the expression of the epidermal growth factor (EGF) system in prostate tissue and secretions obtained from patients with benign prostatic hyperplasia (BPH) treated with or without finasteride (which primarily targets the androgen-sensitive secretory epithelial cells in the prostate, with little effect on basal epithelial and stromal cells).",

keywords = "Epidermal Growth Factor, Finasteride, Glycoproteins, Growth Substances, Humans, Immunohistochemistry, Intercellular Signaling Peptides and Proteins, Male, Prospective Studies, Prostatic Hyperplasia, Receptor, Epidermal Growth Factor, Receptor, erbB-2, Transforming Growth Factor alpha",

author = "Niels T{\o}rring and Jensen, {Klaus M{\o}ller-Ernst} and L Lund and Nielsen, {J E} and Djurhuus, {Jens Christian} and Poulsen, {S S} and Ebba Nex{\o} and Poulsen, {Steen Seier}",

year = "2002",

month = apr,

day = "1",

language = "English",

volume = "89",

pages = "583--90",

journal = "BJU International",

issn = "1464-4096",

publisher = "Wiley-Blackwell",

number = "6",

}

TY - JOUR

T1 - Possible autocrine loop of the epidermal growth factor system in patients with benign prostatic hyperplasia treated with finasteride: a placebo-controlled randomized study

AU - Tørring, Niels

AU - Jensen, Klaus Møller-Ernst

AU - Lund, L

AU - Nielsen, J E

AU - Djurhuus, Jens Christian

AU - Poulsen, S S

AU - Nexø, Ebba

AU - Poulsen, Steen Seier

PY - 2002/4/1

Y1 - 2002/4/1

N2 - To analyse the expression of the epidermal growth factor (EGF) system in prostate tissue and secretions obtained from patients with benign prostatic hyperplasia (BPH) treated with or without finasteride (which primarily targets the androgen-sensitive secretory epithelial cells in the prostate, with little effect on basal epithelial and stromal cells).

AB - To analyse the expression of the epidermal growth factor (EGF) system in prostate tissue and secretions obtained from patients with benign prostatic hyperplasia (BPH) treated with or without finasteride (which primarily targets the androgen-sensitive secretory epithelial cells in the prostate, with little effect on basal epithelial and stromal cells).

KW - Epidermal Growth Factor

KW - Finasteride

KW - Glycoproteins

KW - Growth Substances

KW - Humans

KW - Immunohistochemistry

KW - Intercellular Signaling Peptides and Proteins

KW - Male

KW - Prospective Studies

KW - Prostatic Hyperplasia

KW - Receptor, Epidermal Growth Factor

KW - Receptor, erbB-2

KW - Transforming Growth Factor alpha

M3 - Journal article

C2 - 11942969

SN - 1464-4096

VL - 89

SP - 583

EP - 590

JO - BJU International

JF - BJU International

IS - 6

ER -

Possible autocrine loop of the epidermal growth factor system in patients with benign prostatic hyperplasia treated with finasteride: a placebo-controlled randomized study

Abstract

Keywords

Fingerprint

Cite this